RecoMed

ื˜ื™ืคื•ืœ ื‘ืื ืžื™ื” ื‘ื›ืคืจ ืงืืกื

ื ืžืฆื ืจื•ืคื ืคื ื™ืžืื™ ืžื•ืžืœืฅ ืœื˜ื™ืคื•ืœ ื‘ืื ืžื™ื” ื‘ื›ืคืจ ืงืืกื.

ืจื•ืคืื™ื ืฉื–ืžื™ื ื™ื ืœืคื ื™ื™ื” ื™ืฉื™ืจื” ืžื•ืคื™ืขื™ื ืจืืฉื•ื ื™ื ยท ืื™ืš ืื ื—ื ื• ืžื“ืจื’ื™ื

  1. ืžื•ืžื—ื” ื‘ืจืคื•ืื” ืคื ื™ืžื™ืช ื‘ื›ืคืจ ืงืืกื

    ื›ืคืจ ืงืืกื

    ืฉืคื•ืช: ืขื‘ืจื™ืช ยท ืื ื’ืœื™ืช

ื˜ื™ืคื•ืœ ื‘ืื ืžื™ื” ืœื™ื“ ื›ืคืจ ืงืืกื

ืจื•ืคืื™ื ื‘ืžืจื—ืง ืฉืœ ืขื“ 20 ืงืดืž ืžื›ืคืจ ืงืืกื

  1. ื˜ื™ืคื•ืœ ื‘ื›ืฃ ืจื’ืœ ืกื•ื›ืจืชื™ืช ื•ื‘ืคืฆืขื™ ืœื—ืฅ (ื–ื™ื”ื•ื, ื ืžืง ืื• ื›ื™ื‘ ื‘ื›ืฃ ื”ืจื’ืœ)

    ื˜ื™ืคื•ืœ ื‘ืืจื™ืชืจื•ืคื•ื™ืื˜ื™ืŸ (EPO)

    ืชืœ ืื‘ื™ื‘ ยท 19 ืงืดืž

    ืฉืคื•ืช: ืขื‘ืจื™ืช ยท ืื ื’ืœื™ืช ยท ืจื•ืกื™ืช